Mein Warenkorb

CD99

CD99 Molekülinformation

Englischer NameCD99 antigenAnzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel1Target-Alias12E7,E2 antigen,Protein MIC2,T-cell surface glycoprotein E2
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Englischer NameCD99 antigen
Target-Alias12E7,E2 antigen,Protein MIC2,T-cell surface glycoprotein E2
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel1
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical

CD99 Produktliste

  • Attribut

    Protein (3)Antibody (1)

  • Produktbibliothek

    Online (4)

  • Spezies

    Human (3)Rabbit (1)

  • Etikett

    His Tag (1)His Tag & Avi Tag (1)- (1)Llama IgG Fc Tag (1)

  • Marker

    Unconjugated (3)Biotin-labeled (1)

CD99 Molekülhintergrund

CD99 antigen is also known as MIC2, single-chain type-1 glycoprotein, HBA71, MIC2X, MIC2Y, MSK5X, 12E7, which belongs to the CD99 family. CD99 / MIC2 is expressed on all leukocytes but highest on thymocytes. Involved in T-cell adhesion processes and in spontaneous rosette formation with erythrocytes. CD99 / MIC2 plays a role in a late step of leukocyte extravasation helping leukocytes to overcome the endothelial basement membrane. CD99 acts at the same site as, but independently of PECAM1. There is also experimental evidence that it binds to cyclophilin A.

CD99 Molekülalias

CD99,HBA71,MIC2,MIC2X,MIC2Y,MSK5X,12E7

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
Anti-CD99 CAR T-cell therapy (Wuhan Bio-Raid)BRD-03Phase 2 ClinicalWuhan BioRaid Biotechnology Co LtdOsteosarcoma; Sarcoma
Details
  • Molekülinformation
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns